Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) [Phase 2]
Phase 2 study evaluating novel approaches to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation, with res…
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating ofatumumab plus bendamustine hydrochloride, with or without bortezomib, in untreated follicular lymphoma; the study…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma [Phase 2]
Phase 2 trial assessing denintuzumab mafodotin (SGN-CD19A) with RCHOP/RCHP vs RCHOP alone in diffuse large B-cell lymphoma and follicular ly…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO) [Phase 1, Phase 2]
Clinical trial updates for duvelisib in combination with rituximab or obinutuzumab in previously untreated CD20+ follicular lymphoma; the st…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma [Phase 3]
Phase 3 trial of duvelisib plus rituximab versus rituximab alone in previously treated follicular lymphoma was terminated, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: A Study of Enzastaurin in Participants With Follicular Lymphoma [Phase 2]
Phase 2 trial update for enzastaurin in follicular lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) [Phase 3]
Phase 3 trial update for PF-05280586 (rituximab-Pfizer) vs MabThera (rituximab-EU) as first-line treatment in CD20-positive, low tumor burde…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating Velcade (bortezomib) plus Zevalin in relapsed or refractory follicular lymphoma has terminated with results post…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Safety and Efficacy of BKM120 in Relapsed and Refractory NHL [Phase 2]
Phase 2 trial updating safety and efficacy of BKM120 in relapsed/refractory non-Hodgkin lymphomas (diffuse large B-cell, mantle cell, and fo…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma [Phase 1]
Phase 1 trial comparing pharmacokinetics and pharmacodynamics of BI 695500 versus Rituximab as first-line treatment in low tumor burden foll…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Lenalidomide and R-CHOP in B-cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of lenalidomide with R-CHOP in various B-cell lymphomas; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma [Phase 2]
Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning for relapsed folli…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating a triple regimen of devimistat (CPI-613), bendamustine hydrochloride, and rituximab in relapsed or refractory B-cel…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma [Phase 2]
A Phase 2 proof-of-concept study evaluated daratumumab in relapsed/refractory mantle cell lymphoma, diffuse large B-cell lymphoma, and folli…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) [Phase 2]
Phase 2 trial update for nivolumab in relapsed or refractory follicular lymphoma completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas [Phase 1, Phase 2]
Clinical trial evaluating vorinostat in combination with chemotherapy and rituximab for HIV-related and other aggressive B-cell lymphomas; t…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study evaluating alisertib with or without rituximab in relapsed or refractory B-cell non-Hodgkin lymphomas was terminated; results …
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine and rituximab followed by 90-yttrium ibritumomab tiuxetan for untreated follicular lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients [Phase 2]
Phase 2 trial evaluating a three-drug regimen (Tacrolimus, Bortezomib, and Thymoglobulin) to prevent low-toxicity graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma [Phase 2]
This is a Phase 2 clinical trial evaluating ibrutinib in patients with relapsed or refractory follicular lymphoma. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Safety Study of SGN-CD70A in Cancer Patients [Phase 1]
A Phase 1 safety study of SGN-CD70A in renal cell carcinoma and several lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating pinatuzumab vedotin or polatuzumab vedotin in combination with rituximab or obinutuzumab for relapsed/refractory …
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers [Phase 3]
Phase 3 trial update on the efficacy and safety of ibrutinib in patients with chronic lymphocytic leukemia and indolent B-cell lymphomas who…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: BRIEF Bendamustine and Rituximab In Elderly Follicular [Phase 2]
A Phase 2 trial of Bendamustine and Rituximab in elderly patients with Follicular lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating vorinostat in multiple low-grade non-Hodgkin lymphomas, including MALT lymphoma, nodal marginal zone lymphoma, foll…